Gainers

  • CLPS IncorporationCLPS jumped 56.13 percent to close at $16.80 on Wednesday after the company released a letter to shareholders. The China-based company said it’s working on “enhancing its original financial technology service offerings to expand to international markets, serve international customers, and provide innovative solutions and products to support more world-class technology customers.”
  • Neptune Technologies & Bioressources Inc.NEPT jumped 37.77 percent to close at $4.45 on Wednesday after surging 31.84 percent on Tuesday.
  • Naked Brand Group IncNAKD shares rose 36.66 percent to close at $8.50. Naked Brand and Bendon Limited reported that they have completed their earlier announced merger.
  • Eidos Therapeutics, Inc.EIDX climbed 36 percent to close at $23.12. Eidos Therapeutics priced its IPO at $17 per share.
  • Caladrius Biosciences IncCLBS gained 30.71 percent to close at $8.64 on Wednesday. Caladrius Biosciences shares climbed over 67 percent Tuesday after announcing the company’s CD34+ cell therapy program received FDA regenerative medicine advanced therapy designation for treating refractory angina.
  • Arcimoto, Inc. FUVgained 26.2 percent to close at $4.48.
  • Intelsat S.A.I shares rose 20.3 percent to close at $19.32 on Wednesday. RBC Capital upgraded Intelsat from Sector Perform to Outperform.
  • New Age Beverages CorporationNBEV gained 20.19 percent to close at $2.50.
  • ADOMANI, Inc. ADOMgained 18.58 percent to close at $1.34 following last night’s PR that the company will enter U.S. electric truck market.
  • Apollo Endosurgery, Inc. APENjumped 18.21 percent to close at $6.62. Apollo Endosurgery priced its 3.747 million share offering at $5.50 per share.
  • Tesaro, Inc.TSRO shares climbed 16.25 percent to close at $46.49.
  • PolarityTE, Inc. COOLgained 16.22 percent to close at $37.05.
  • Intelligent Systems Corporation INSrose 15.53 percent to close at $9.30.
  • Winnebago Industries, Inc.WGO shares jumped 14.87 percent to close at $46.35 after the company reported stronger-than-expected results for its third quarter.
  • Castlight Health, Inc. CSLTclimbed 14.47 percent to close at $4.35.
  • KalVista Pharmaceuticals, Inc. KALVrose 14.09 percent to close at $8.99.
  • Social Reality, Inc. SRAXrose 13.76 percent to close at $5.29.
  • TPI Composites, Inc. TPICgained 13.29 percent to close at $29.24.
  • Ultra Petroleum Corp. UPLrose 12.14 percent to close at $2.31 on Wednesday.
  • Actuant Corporation ATUgained 11.95 percent to close at $29.05 following Q3 earnings.
  • Synaptics Incorporated . SYNAclimbed 11.51 percent to close at $54.46 in reaction to M&A news. The company designs technologies to bring innovative and intuitive user experiences to intelligent devices and confirmed Tuesday afternoon it is in talks to sell itself to Dialog Semiconductor.
  • Akoustis Technologies, Inc. AKTSrose 11.45 percent to close at $7.59.
  • Fluidigm Corporation FLDMsurged 11.29 percent to close at $5.52.
  • Navigator Holdings Ltd. NVGSshares gained 11.21 percent to close at $12.40.
  • Stoneridge, Inc. SRIsurged 11.08 percent to close at $35.60 on Wednesday.
  • STAAR Surgical Company STAArose 11.05 percent to close at $32.65 after the company reported the resolution of FDA Warning Letter.
  • Sangamo Therapeutics, Inc. SGMOgained 9.73 percent to close at $18.05. Bank of America initiated coverage on Sangamo Therapeutics with a Buy rating and a $24 price target.
  • Moleculin Biotech, Inc. MBRXrose 7.96 percent to close at $2.17. The clinical stage pharmaceutical company that develops oncology drug candidates said it received approval from the Polish National Office to begin a phase 1/2 clinical trial of its Annamycin for the treatment of relapsed or refractory acute myeloid leukemia.
  • H. Glatfelter Company GLTclimbed 7.83 percent to close at $19.82. DA Davidson upgraded P. H. Glatfelter from Neutral to Buy.
  • Teligent, Inc. TLGTgained 6.22 percent to close at $3.93 after the company reported the FDA approval of Fluocinonide gel, 0.05%.

 

Losers

  • Anika Therapeutics Inc ANIKshares tumbled 37.62 percent to close at $28.77 on Wednesday after reporting top-line results from CINGAL 16-02 clinical trial in knee osteoarthritis study did not achieve statistical significance at primary endpoint.
  • Gevo, Inc.GEVO shares declined 35.74 percent to close at $12.53 after surging 53.54 percent on Tuesday.
  • InVivo Therapeutics Holdings Corp. NVIVfell 26.74 percent to close at $3.37 on Wednesday.
  • ReShape Lifesciences Inc. RSLSdropped 23.15 percent to close at $2.49 after reporting a $1.5 million registered direct offering priced at-the-market.
  • Astrotech CorporationASTC declined 21.7 percent to close at $4.98. Astrotech shares surged 217.44 percent Tuesday after the company’s subsidiary, 1st Detect, announced its TRACER 1000 Explosives Trace Detector was accepted into the European Evaluation Process for airport checkpoint screening.
  • Kazia Therapeutics Limited KZIAdeclined 18.29 percent to close at $3.53.
  • Apollo Medical Holdings, Inc.AMEH dropped 17.67 percent to close at $20.04.
  • Solid Biosciences Inc. SLDBdropped 17.05 percent to close at $35.67.
  • Catabasis Pharmaceuticals, Inc. CATBslipped 14.71 percent to close at $0.87 after the company reported pricing of its $42 million underwritten public offering.
  • Puxin LimitedNEW fell 12.97 percent to close at $26.11.
  • com Holdings, Inc. ALRMdeclined 12.76 percent to close at $39.51.
  • Scholar Rock Holding Corporation SRRKfell 11.91 percent to close at $22.55.
  • Carvana Co. CVNAfell 11.36 percent to close at $38.72.
  • Tantech Holdings Ltd TANHshares dipped 11.35 percent to close at $2.89 on Wednesday.
  • Adamis Pharmaceuticals Corporation ADMPtumbled 11.26 percent to close at $3.35.
  • Galectin Therapeutics, Inc. GALTdropped 11.06 percent to close at $7.96.
  • NF Energy Saving Corporation NFECfell 9.75 percent to close at $2.50.
  • Starbucks Corporation SBUXshares slipped 9.07 percent to close at $52.22 after announcing weak third-quarter guidance and the closing of 150 stores.
  • Oracle Corporation ORCLshares fell 7.46 percent to close at $42.82. Oracle reported better-than-expected earnings for its fourth quarter, but issued weak guidance for the first quarter.
  • La-Z-Boy Incorporated LZBshares fell 4.51 percent to close at $31.75. La-Z-Boy reported upbeat earnings for its fourth quarter, while sales missed estimates.